Position in REPL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$8,721,755
-$2,158,393 QoQ
Shares Held
1,140,099
+1.9% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 89%
Shared 6%
None 5%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. REPL ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in REPL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,721,755 | 1,140,099 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $10,880,148 | 1,119,357 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,243,787 | 1,251,501 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,827,075 | 1,165,455 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,261,250 | 949,872 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,423,552 | 778,163 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,976,935 | 545,341 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,496,129 | 610,681 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,989,048 | 977,852 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $11,152,627 | 1,322,969 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $24,467,726 | 1,430,025 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $29,824,903 | 1,284,449 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $19,010,685 | 1,076,483 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,744,151 | 725,888 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $11,179,836 | 647,356 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,269,017 | 473,056 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,847,861 | 344,397 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,300,126 | 232,477 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $5,197,670 | 175,360 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,595,347 | 67,552 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,016,288 | 33,310 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,253,456 | 32,856 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $756,345 | 32,856 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $316,961 | 12,755 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||